Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Informing the Population of Their Level of Protection Against COVID-19 in Monaco: a Prospective Study (MonaVacc)

NCT05084950 is registered in ClinicalTrials.gov with Centre Scientifique de Monaco as lead sponsor.

NCT NCT05084950
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05084950 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Informing the Population of Their Level of Protection Against COVID-19 in Monaco: a Prospective Study (MonaVacc)
Lead sponsor
Centre Scientifique de Monaco
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2021
Completion date
December 31, 2022
Enrollment
10,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antibody, covid-19, sars-cov-2, vaccines